Evidence map›Paper›PMID 34976315›Full record

ReviewComputational and structural biotechnology journal2022

Yeast Crf1p: An activator in need is an activator indeed.

Sanjay Kumar, Muneera Mashkoor, Anne Grove

Open access · goldAbstract readReview
In one paragraph

Review in Computational and structural biotechnology journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Deletion ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  5. Quiescence inAnnual review of genetics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sanjay KumarDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
Muneera MashkoorDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
Anne GroveDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA.
Louisiana State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribosome biogenesis is an energetically costly process, and tight regulation is required for stoichiometric balance between components. This requires coordination of RNA polymerases I, II, and III. Lack of nutrients or the presence of stress leads to downregulation of ribosome biogenesis, a process for which mechanistic target of rapamycin complex I (mTORC1) is key. mTORC1 activity is communicated by means of specific transcription factors, and in yeast, which is a primary model system in which transcriptional coordination has been delineated, transcription factors involved in regulation of ribosomal protein genes include Fhl1p and its cofactors, Ifh1p and Crf1p. Ifh1p is an activator, whereas Crf1p has been implicated in maintaining the repressed state upon mTORC1 inhibition. Computational analyses of evolutionary relationships have indicated that Ifh1p and Crf1p descend from a common ancestor. Here, we discuss recent evidence, which suggests that Crf1p also functions as an activator. We propose a model that consolidates available experimental evidence, which posits that Crf1p functions as an alternate activator to prevent the stronger activator Ifh1p from re-binding gene promoters upon mTORC1 inhibition. The correlation between retention of Crf1p in related yeast strains and duplication of ribosomal protein genes suggests that this backup activation may be important to ensure gene expression when Ifh1p is limiting. With ribosome biogenesis as a hallmark of cell growth, failure to control assembly of ribosomal components leads to several human pathologies. A comprehensive understanding of mechanisms underlying this process is therefore of the essence.

Indexed as

CK2, casein kinase 2Crf1, corepressor with forkhead likeCrf1pFHA, forkhead-associatedFHB, forkhead-bindingFhl1, forkhead likeFKBP, FK506 binding proteinFpr1, FK506-sensitive proline rotamaseGene regulationHmo1, high mobility groupIfh1, interacts with forkhead likeIfh1pmTORC1mTORC1, mechanistic target of rapamycin complex 1Rap1, repressor/activator proteinRASTR, ribosome assembly stress responseRiBi, ribosome biogenesisRibosomal proteinRibosome biogenesisRP, ribosomal proteinSfp1, split finger proteinWGD, whole genome duplication

Identifiers

PMID34976315
PMCPMC8688861
OpenAlexW4200002520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.